Meta AnalysisID 4769
麦芽酚铁治疗缺铁性贫血患者：系统评价
CRD42020202111
Does Ferric maltol show good therapeutic outcome not only in iron deficiency anaemia as well as patients with existing complications like Inflammatory Bowel Disease, Chronic renal failure, renal insufficiency?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 4769
- Evidence Id
- 13327
- Core Evidence Id
- 13327
- Source Meta Analysis Id
- 4735
- Herb2 Meta Analysis Id
- HBMA004735
- Crd Id
- CRD42020202111
- Title
- Therapeutic use of ferric maltol in patients with iron deficiency anaemia: a systematic review.
- Review Question
- Does Ferric maltol show good therapeutic outcome not only in iron deficiency anaemia as well as patients with existing complications like Inflammatory Bowel Disease, Chronic renal failure, renal insufficiency?
- Study Type Included
- Full research work RCTs
- Condition Being Studied
- Iron is an essential element for the production of blood. About 70 % of the body's iron is found in the RBCs of our blood called haemoglobin and in muscle cells called myoglobin. Anemia is a common extraintestinal manifestation of inflammatory bowel disease (IBD) and is frequently overlooked as a complication. Patients with IBD are commonly found to have iron deficiency anaemia (IDA) secondary to chronic blood loss, and impaired iron absorption due to tissue inflammation.
- Participant
- Inclusion: -iron deficiency patients treated with ferric maltol. -ferric maltol treated inpatient with iron deficiency anaemia and further complications. Exclusion: -anaemic patients non treated with ferric maltol as a major treatment. -iron-deficiency anaemic patients treated with multiple drugs.
- Animal
- Human Disease Modelled
- Intervention
- ferric maltol use in iron deficiency anemia
- Comparator Control
- either placebo/other drugs
- Main Outcome
- The baseline of Hemoglobin (Hb) and ferritin responses after administration of ferric maltol. Measures of effect Mean standard deviation
- Outcome Measure
- Additional Outcome
- 1.Hemoglobin (Hb) and ferritin response from baseline. 2. Quality of Life; 3. Adverse events related to existing IV or oral iron.therapy. Measures of effect safety and efficacy profile of patients
- Study Method
- Intervention, Prevention, Prognostic, Systematic review
- Keyword
- Anemia, Iron-Deficiency; Ferric Compounds; Humans; Pyrones; ferric maltol
- Contact
- SARVESH SABARATHINAM [email protected]
- Organisational Affiliation
- SRM Institute of Science and Technology
- Funding Source
- No fundings
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- India
- Review Stage
- Review Ongoing
- First Submission Date
- 2020-08-01
- Registration Date
- 2020-09-01
- Anticipated Start Date
- 2020-07-20
- Anticipated Completion Date
- 2020-08-31
- Title Cn
- 麦芽酚铁治疗缺铁性贫血患者：系统评价
- Title En
- Therapeutic use of ferric maltol in patients with iron deficiency anaemia: a systematic review.
- Bilingual Status
- complete